Literature DB >> 2991611

The use of collagenase in the treatment of Peyronie's disease.

M K Gelbard, A Lindner, J J Kaufman.   

Abstract

Purified clostridial collagenase was administered intralesionally in 31 men with Peyronie's disease. Within 4 weeks of treatment 20 patients showed an objective improvement. Pain was eliminated in 13 of 14 patients with this complaint at presentation within the same 4-week period. The ability to have intercourse was restored in 3 of 4 patients with this problem. Except for a small corporeal rupture at the site of injection in 1 patient, no significant untoward effects were noted. During the mean 9.8-month followup 1 recurrence of bending was noted.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991611     DOI: 10.1016/s0022-5347(17)47123-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

Review 2.  Intralesional collagenase in the treatment of Peyronie's disease.

Authors:  Stanton C Honig
Journal:  Ther Adv Urol       Date:  2014-04

Review 3.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 4.  Nonsurgical treatment options in Peyronie's Disease: 2016 update.

Authors:  Raidh A Talib; Mohammed Abdulkareem Ibrahim; Önder Cangüven
Journal:  Turk J Urol       Date:  2016-12

5.  Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective.

Authors:  James Anaissie; Wayne J G Hellstrom; Faysal A Yafi
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

6.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

Review 7.  Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects.

Authors:  María Alejandra Egui Rojo; Ignacio Moncada Iribarren; Joaquín Carballido Rodriguez; Juan Ignacio Martinez-Salamanca
Journal:  Ther Adv Urol       Date:  2014-10

Review 8.  Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.

Authors:  Elizabeth J Traore; William Wang; Faysal A Yafi; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2016-03-22

Review 9.  Peyronie's disease.

Authors:  J C Gingell; K M Desai
Journal:  BMJ       Date:  1988-12-10

10.  Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?

Authors:  Chris Poullis; Majid Shabbir; Ian Eardley; John Mulhall; Suks Minhas
Journal:  BJU Int       Date:  2016-02-25       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.